cached image

Rajiv Bhat, Ph.D.

School of Biotechnology Jawaharlal Nehru University, New Delhi 
Protein folding, stability and aggregation; Protein-solvent interactions
"Prof. Rajiv Bhat"
Mean distance: 8.89
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Verma G, Singh P, Bhat R. (2020) Disorder under stress: Role of polyol osmolytes in modulating fibrillation and aggregation of intrinsically disordered proteins. Biophysical Chemistry. 264: 106422
Singh P, Bhat R. (2019) Binding of Noradrenaline to native and intermediate states during fibrillation of α-Synuclein leads to the formation of stable and structured cytotoxic species. Acs Chemical Neuroscience
Roy S, Bhat R. (2018) Suppression, Disaggregation, and Modulation of γ-Synuclein Fibrillation Pathway by Green Tea Polyphenol EGCG. Protein Science : a Publication of the Protein Society
Roy S, Bhat R. (2018) Effect of polyols on the structure and aggregation of recombinant human γ-Synuclein, an intrinsically disordered protein. Biochimica Et Biophysica Acta
Jain MK, Singh P, Roy S, et al. (2018) Comparative analysis of the conformation, aggregation, interaction and fibril morphologies of human α, β and γ synuclein proteins. Biochemistry
Peng WX, Xiong EM, Ge L, et al. (2015) Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. Experimental Cell Research
Ali NM, Bhat R, Rao SB. (2015) Concurrent Presentation of Erythrodermic Lichen Planus and Squamous Cell Carcinoma: Coincidence or Malignant Transformation? Indian Journal of Dermatology. 60: 457-60
Bhat RM, Monteiro RC, Bala N, et al. (2015) Subcutaneous mycoses in coastal Karnataka in south India. International Journal of Dermatology
Patrao NA, Bhat RM, Dandekeri S, et al. (2015) Diffuse cutaneous leishmaniasis in coexistence with leprosy. International Journal of Dermatology
Dogra S, D S K, Budamakuntla L, et al. (2015) Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study. Journal of the American Academy of Dermatology. 73: 331-333.e1
See more...